Andrew Oxtoby's Insider Trades & SAST Disclosures

Andrew Oxtoby's most recent trade in Kalaris Therapeutics Inc. was a trade of 287,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 10, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kalaris Therapeutics Inc.
Andrew Oxtoby Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2025 287,000 287,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades